BR112017019750A2 - processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol - Google Patents
processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinolInfo
- Publication number
- BR112017019750A2 BR112017019750A2 BR112017019750A BR112017019750A BR112017019750A2 BR 112017019750 A2 BR112017019750 A2 BR 112017019750A2 BR 112017019750 A BR112017019750 A BR 112017019750A BR 112017019750 A BR112017019750 A BR 112017019750A BR 112017019750 A2 BR112017019750 A2 BR 112017019750A2
- Authority
- BR
- Brazil
- Prior art keywords
- menaquinol
- crystalline form
- preparing
- pharmaceutical
- nutraceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/06—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by conversion of non-aromatic six-membered rings or of such rings formed in situ into aromatic six-membered rings, e.g. by dehydrogenation
- C07C37/07—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by conversion of non-aromatic six-membered rings or of such rings formed in situ into aromatic six-membered rings, e.g. by dehydrogenation with simultaneous reduction of C=O group in that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/68—Purification; separation; Use of additives, e.g. for stabilisation
- C07C37/70—Purification; separation; Use of additives, e.g. for stabilisation by physical treatment
- C07C37/84—Purification; separation; Use of additives, e.g. for stabilisation by physical treatment by crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
- C07C39/225—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/66—Preparation of oxygen-containing organic compounds containing the quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
a presente invenção refere-se a formas sólidas de menaquinol e processos para obtê-las por meio de redução química ou enzimática da menaquinona. tais formas sólidas possuem alta estabilidade quanto a oxidação, o que permite um uso efetivo do menaquinol nas formulações mais comuns em que se usa vitamina k2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB20150528 | 2015-03-20 | ||
PCT/IB2016/051528 WO2016151447A1 (en) | 2015-03-20 | 2016-03-18 | Solid forms of menaquinols |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017019750A2 true BR112017019750A2 (pt) | 2018-05-29 |
Family
ID=53284441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017019750A BR112017019750A2 (pt) | 2015-03-20 | 2016-03-18 | processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol |
Country Status (15)
Country | Link |
---|---|
US (1) | US10563270B2 (pt) |
EP (1) | EP3270902A1 (pt) |
JP (1) | JP2018514507A (pt) |
KR (1) | KR20170128333A (pt) |
CN (1) | CN107428645A (pt) |
AU (1) | AU2016238473B2 (pt) |
BR (1) | BR112017019750A2 (pt) |
CA (1) | CA2979997A1 (pt) |
EA (1) | EA032261B1 (pt) |
GE (1) | GEP20197040B (pt) |
IL (1) | IL254502B (pt) |
MX (1) | MX2017011934A (pt) |
PH (1) | PH12017501692A1 (pt) |
WO (1) | WO2016151447A1 (pt) |
ZA (1) | ZA201706282B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10688064B2 (en) | 2018-06-08 | 2020-06-23 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating tissue calcification |
SG11202012055PA (en) | 2018-06-08 | 2021-01-28 | Epizon Pharma Inc | Methods and compositions for preventing or treating calciphylaxis |
CA3111108A1 (en) * | 2018-09-12 | 2020-03-19 | Epizon Pharma, Inc. | Menaquinol compositions and methods of treatment |
EP4001421A1 (en) * | 2020-11-16 | 2022-05-25 | Endektovet Ltd | Method for obtaining oil extract of menaquinone-7 from fermentation broth |
CN112778092B (zh) * | 2020-12-31 | 2023-03-24 | 玉溪健坤生物药业有限公司 | 一种还原型维生素k2的制备方法及其用途 |
CN115304464B (zh) * | 2022-09-02 | 2023-03-14 | 新拓洋生物工程有限公司 | 一种维生素k2(35)的提取方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003137716A (ja) | 2001-10-30 | 2003-05-14 | Eau De Faveur:Kk | 皮膚の外用剤 |
JP5001515B2 (ja) * | 2004-09-17 | 2012-08-15 | 株式会社カネカ | 還元型ビタミンkの製造方法 |
EP2060256A1 (en) * | 2007-11-16 | 2009-05-20 | Gnosis S.p.A. | Pharmaceutical and nutraceutical compositions based on menaquinols |
RU2606767C2 (ru) * | 2011-05-20 | 2017-01-10 | Фрисланд Брандз Б.В. | Композиция, содержащая витамин k2 |
-
2016
- 2016-03-18 MX MX2017011934A patent/MX2017011934A/es unknown
- 2016-03-18 CA CA2979997A patent/CA2979997A1/en not_active Abandoned
- 2016-03-18 EA EA201791845A patent/EA032261B1/ru not_active IP Right Cessation
- 2016-03-18 JP JP2017548911A patent/JP2018514507A/ja active Pending
- 2016-03-18 US US15/558,871 patent/US10563270B2/en active Active
- 2016-03-18 AU AU2016238473A patent/AU2016238473B2/en not_active Ceased
- 2016-03-18 WO PCT/IB2016/051528 patent/WO2016151447A1/en active Application Filing
- 2016-03-18 BR BR112017019750A patent/BR112017019750A2/pt not_active Application Discontinuation
- 2016-03-18 EP EP16725218.8A patent/EP3270902A1/en not_active Withdrawn
- 2016-03-18 GE GEAP201614586A patent/GEP20197040B/en unknown
- 2016-03-18 KR KR1020177026101A patent/KR20170128333A/ko unknown
- 2016-03-18 CN CN201680015954.7A patent/CN107428645A/zh active Pending
-
2017
- 2017-09-14 IL IL254502A patent/IL254502B/en not_active IP Right Cessation
- 2017-09-15 PH PH12017501692A patent/PH12017501692A1/en unknown
- 2017-09-15 ZA ZA2017/06282A patent/ZA201706282B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GEP20197040B (en) | 2019-11-11 |
WO2016151447A1 (en) | 2016-09-29 |
IL254502B (en) | 2020-09-30 |
KR20170128333A (ko) | 2017-11-22 |
MX2017011934A (es) | 2018-02-09 |
EA201791845A1 (ru) | 2018-02-28 |
ZA201706282B (en) | 2019-01-30 |
EA032261B1 (ru) | 2019-04-30 |
AU2016238473A1 (en) | 2017-08-24 |
CN107428645A (zh) | 2017-12-01 |
CA2979997A1 (en) | 2016-09-29 |
IL254502A0 (en) | 2017-11-30 |
JP2018514507A (ja) | 2018-06-07 |
PH12017501692A1 (en) | 2018-03-19 |
EP3270902A1 (en) | 2018-01-24 |
US20180066326A1 (en) | 2018-03-08 |
US10563270B2 (en) | 2020-02-18 |
AU2016238473B2 (en) | 2020-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017019750A2 (pt) | processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol | |
NI201700095A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
BR112018076126A2 (pt) | compostos heterocíclicos como antibacterianos | |
BR112016024644A2 (pt) | vacinas de ácido nucleico | |
UY34701A (es) | Formas sólidas de un profármaco de nucleótidos de tiofosforamidato | |
BR112015015891A8 (pt) | Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica | |
MX2020003841A (es) | Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos. | |
UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
CL2017002082A1 (es) | Nuevas proteínas especificas para pioverdina y pioquelina | |
DOP2016000253A (es) | Nuevos compuestos | |
BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
CL2017000715A1 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo | |
BR112017003346A2 (pt) | derivados de pirazolopiridina, seus usos, e composição farmacêutica | |
CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
BR112017004231A2 (pt) | processo para produzir um precipitado estável enriquecido em ficobiliproteínas | |
BR112016025876A8 (pt) | composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 | |
BR112018010605A2 (pt) | nanoemulsões de bebidas produzidas por processamento de alto cisalhamento | |
CL2018000158A1 (es) | Composiciones y métodos para inhibir la expresión del gen alas1 (divisional de solicitud 20160772) | |
BR112018014590A2 (pt) | formulações/composições compreendendo um inibidor de btk | |
BR112017021191A2 (pt) | um extrato de indigo naturalis e um processo para preparar o mesmo | |
BR112016024421A2 (pt) | composição farmacêutica, cápsula e uso da composição farmacêutica | |
BR112017017310A2 (pt) | composições lipídicas | |
BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento | |
BR112017010804A2 (pt) | polímero em multi-estágio, sua composição, seu método de preparação, seu uso e composição compreendendo o mesmo | |
UY36217A (es) | Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |